daniel catenacci, md, shares opinion on the role of checkpoint inhibitors for gi malignancies
Published 4 years ago • 263 plays • Length 2:10
Download video MP4
Download video MP3
Similar videos
-
1:01
daniel catenacci, md, on the role of margetuximab to improve treatment outcomes of gi cancers
-
3:11
daniel catenacci, md, discusses margetuximab in the treatment of esophageal and gastric cancer
-
2:43
daniel catenacci, md, elaborates on the outcomes of the javelin 100 study presented at asco gi 2020
-
1:16
dr. he on the potential of immune checkpoint inhibitors in gi cancers
-
1:23
the role of immune checkpoint inhibitors in mcrpc
-
7:34
checkpoint inhibitors: emerging role in ge cancer
-
2:00
dr. catenacci on the challenges of developing novel therapies in gastroesophageal cancer
-
2:40
the current role of checkpoint inhibitors in head and neck cancer
-
18:50
c15:0 update #1 | human studies and ferroptosis
-
5:33
cancer immune checkpoint inhibitors
-
8:16
cell cycle checkpoints (fl-cancer/02)
-
1:54
which patients with gastric cancer can benefit most from checkpoint inhibitors?
-
1:43
the role of the checkpoint inhibitors in breast cancer
-
53:11
glyco-checkpoints as therapeutic targets in cancer, autoimmunity & infection by dr. g. rabinovich
-
0:50
dr. mita on emergence of checkpoint inhibitors sclc
-
4:38
emerging checkpoint inhibitors for hnscc
-
1:46
determining the optimal timing for immunotherapy in patients with gej cancers
-
6:18
checkpoint inhibitor therapy in prostate cancer
-
22:49
managing side effects of checkpoint inhibitors
-
0:26
nevena damjanov, md, elaborates on the role of tkis in managing 2nd line hcc patients
-
0:58
advancing interest in immune checkpoint blockade for gi cancers
-
2:33
daneng li, md, on impressions of patient reported outcomes from the imbrave 150 study
Clip.africa.com - Privacy-policy